PubRank

Virus DNX2401 and Temozolomide in Recurrent Glioblastoma (D24GBM)

Clinical Trial ID NCT01956734

PubWeight™ 14.29‹?›

🔗 Visit the ClinicalTrials.gov page for NCT01956734

Top papers

Rank Title Journal Year PubWeight™‹?›
1 A mutant oncolytic adenovirus targeting the Rb pathway produces anti-glioma effect in vivo. Oncogene 2000 2.81
2 Trial Watch:: Oncolytic viruses for cancer therapy. Oncoimmunology 2014 1.22
3 Adenovirus-based strategies overcome temozolomide resistance by silencing the O6-methylguanine-DNA methyltransferase promoter. Cancer Res 2007 1.11
4 Sui generis: gene therapy and delivery systems for the treatment of glioblastoma. Neuro Oncol 2015 0.94
5 What next for newly diagnosed glioblastoma? Future Oncol 2015 0.94
6 Oncolytic adenovirus: preclinical and clinical studies in patients with human malignant gliomas. Curr Gene Ther 2009 0.94
7 Overview of current immunotherapeutic strategies for glioma. Immunotherapy 2015 0.89
8 Recent advances in oncolytic adenovirus therapies for cancer. Curr Opin Virol 2016 0.87
9 Moving oncolytic viruses into the clinic: clinical-grade production, purification, and characterization of diverse oncolytic viruses. Mol Ther Methods Clin Dev 2016 0.86
10 Oncolytic viruses and DNA-repair machinery: overcoming chemoresistance of gliomas. Expert Rev Anticancer Ther 2006 0.85
11 EXPLORING THE ANTITUMOR EFFECT OF VIRUS IN MALIGNANT GLIOMA. Drugs Future 2016 0.84
12 Replication-Competent Viruses as Cancer Immunotherapeutics: Emerging Clinical Data. Hum Gene Ther 2015 0.83
13 Gene therapy for malignant glioma. Mol Cell Ther 2014 0.83
14 Adenoviral vector-mediated gene therapy for gliomas: coming of age. Expert Opin Biol Ther 2014 0.82
15 Oncolytic adenovirus research evolution: from cell-cycle checkpoints to immune checkpoints. Curr Opin Virol 2015 0.82
16 Anti-Cancer Stem-like Cell Compounds in Clinical Development - An Overview and Critical Appraisal. Front Oncol 2016 0.80
17 Unlocking the promise of oncolytic virotherapy in glioma: combination with chemotherapy to enhance efficacy. Ther Deliv 2015 0.78
18 Recent advances and future of immunotherapy for glioblastoma. Expert Opin Biol Ther 2016 0.77
19 Emerging immunotherapies for glioblastoma. Expert Opin Emerg Drugs 2016 0.77
20 Chemovirotherapy: combining chemotherapeutic treatment with oncolytic virotherapy. Oncolytic Virother 2015 0.76
21 Evolution of malignant glioma treatment: from chemotherapy to vaccines to viruses. Neurosurgery 2014 0.75
Next 100